For people who are seriously ill and not eligible for a clinical trial—the main pathway to access investigational medicines—Johnson & Johnson Innovative Medicine (J&J IM) accepts requests for our investigational medicines from their treating physicians. Below are the number of patients to whom J&J IM has provided pre-approval access (PAA) annually since 2015:
| Year | Number or requests approved |
| 2015 | 175 |
| 2016 | 1,901 |
| 2017 | 1,111 |
| 2018 | 726 |
| 2019 | 469 |
| 2020 | 552 |
| 2021 | 991 |
| 2022 | 1,539 |
| 2023 | 1,781 |
| 2024 | 637 |
| Total | 9,882 |
For more information about PAA at J&J Innovative Medicine, please click here.